Evaluation of Response to Ritlecitinib Treatment Based on SALT Improvement Scores in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. J of Skin. 2023;7(2):s187. doi:10.25251/skin.7.supp.187